Found: 14
Select item for more details and to access through your institution.
RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009-2016).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies.
- Published in:
- Journal of Pathology, 2018, v. 245, n. 1, p. 19, doi. 10.1002/path.5051
- By:
- Publication type:
- Article
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
- Published in:
- Journal of Pathology, 2016, v. 238, n. 4, p. 562, doi. 10.1002/path.4679
- By:
- Publication type:
- Article
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 10, p. 2384, doi. 10.1002/1878-0261.12764
- By:
- Publication type:
- Article
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00580-3
- By:
- Publication type:
- Article
Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2011, v. 34, n. 1/2, p. 61, doi. 10.1155/2011/393521
- By:
- Publication type:
- Article
Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
- Published in:
- Histopathology, 2019, v. 75, n. 2, p. 236, doi. 10.1111/his.13895
- By:
- Publication type:
- Article
Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as a Suitable Alternative to Resection Material for Mutation Screening in Colorectal Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2019, v. 23, n. 3, p. 383, doi. 10.1007/s40291-019-00388-z
- By:
- Publication type:
- Article
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82737-9
- By:
- Publication type:
- Article
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT.
- Published in:
- Efficacy & Mechanism Evaluation (EME), 2022, v. 9, n. 9, p. vii, doi. 10.3310/HTNB6908
- By:
- Publication type:
- Article
EGFR Amplification in Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer.
- Published in:
- Clinical Trials, 2022, v. 19, n. 2, p. 146, doi. 10.1177/17407745211069879
- By:
- Publication type:
- Article